목적: 한국인 선천성 무홍채증 환자의 임상양상과 분자유전학적 특성을 분석하여 소개한다. 대상과 방법: 홍채형성저하증을 특징으로 임상적으로 진단된 한국인 선천성 무홍채증 환자를 ...

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A102124107
2016
-
510
KCI등재,SCOPUS,ESCI
학술저널
1441-1450(10쪽)
0
0
상세조회0
다운로드목적: 한국인 선천성 무홍채증 환자의 임상양상과 분자유전학적 특성을 분석하여 소개한다. 대상과 방법: 홍채형성저하증을 특징으로 임상적으로 진단된 한국인 선천성 무홍채증 환자를 ...
목적: 한국인 선천성 무홍채증 환자의 임상양상과 분자유전학적 특성을 분석하여 소개한다.
대상과 방법: 홍채형성저하증을 특징으로 임상적으로 진단된 한국인 선천성 무홍채증 환자를 대상으로 하였다. 최대교정시력, 홍채형성저하증의 정도, 황반형성저하증의 정도 및 동반된 이상소견을 기록하여 분석하였다. PAX6 유전자의 변이분석, 복합결찰의존프로브증폭법 분석, 유전체의 분자 핵형 분석 및 후보 유전자 염기서열 분석을 통한 분자유전학적 검사결과를 분석하였다.
결과: 18가계의 총 28명의 환자가 포함되었다. 최대교정시력은 다양하여 시표로 측정이 가능하였던 19명에서 20/400에서 20/25의 범위였고, 그중 20/200 이하의 시력을 보인 환자는 9명이었다(47%). 황반형성저하증은 전 예에서 관찰되었고, 그중 1명은 매우 경증이었다. PAX6 유전자 분석을 시행한 18가계 중 13가계에서 유전자 변이가 발견되었으며, 2개의 새로운 변이(p.Trp162Leufs*38, p.Gly409Arg)가 발견되었다. 발견된 변이 중 3가계에서는 과오돌연변이(missense mutation), 또 다른 3가계에서는 PAX6 유전자 부위의 큰 결손(large chromosomal deletions)을 보였다.
결론: 선천성 무홍채증과 연관된 2개의 새로운 변이를 발견하여 보고하는 바이다. 선천성 무홍채증은 시력을 위협하는 심각한 안구기형이지만, 중심시력, 홍채형성저하증의 정도는 매우 다양하였다. 전체 가계의 72%에서 PAX6 유전자의 돌연변이가 발견되었고, 돌연변이 유무에 관계없이 경증에서 중증까지 다양한 스펙트럼의 임상양상을 보여주었다.
다국어 초록 (Multilingual Abstract)
Purpose: To introduce clinical features and molecular characteristics of Korean patients with congenital aniridia. Methods: Patients with iris hypoplasia were diagnosed clinically as congenital aniridia and were included in the study. Best corrected ...
Purpose: To introduce clinical features and molecular characteristics of Korean patients with congenital aniridia.
Methods: Patients with iris hypoplasia were diagnosed clinically as congenital aniridia and were included in the study. Best corrected visual acuity (BCVA) and associated ocular abnormalities (including severity of iris hypoplasia, nystagmus, keratopathy, and foveal hypoplasia), and findings in optical coherence tomography were analyzed. PAX6 analysis,multiplex ligation-dependent probe amplification (MLPA), genomic molecular karyotyping, and candidate gene sequencing were performed to detect genetic abnormalities.
Results: 28 patients from 18 families were included in the study. BCVA varied from hand motion to 20/25. No manifest nystagmus was found in 3 patients, but the rest of the patients had pendular horizontal nystagmus. Keratopathy was found in 23 patients, cataracts in 12 patients, and glaucoma in 4 patients. All patients had foveal hypoplasia, including one case with a subtle phenotype. The PAX6 mutation was detected in 13 families out of 18;2 (p.Trp162Leufs*38,p.Gly409Arg) were novel,3 families had the miss ensemutation, and 3 families had alargedeletion in the PAX6 gene.
Conclusions: This study adds 2 novel PAX6 mutations related to congenital aniridia to those previously reported. Congenital aniridia is a serious, sight-threatening ocular malformation, but central vision and the degree of iris hypoplasia were highly variable. The PAX6 mutation was detected in 72% of the patients in this study, and there were no specific clinical features differentiating aniridia with and without PAX6 mutations.
참고문헌 (Reference)
1 김종호, "선천무홍채증 환자의 PAX6 유전자의 돌연변이와 임상양상" 대한안과학회 49 (49): 1794-1800, 2008
2 Axton R., "The incidence of PAX6 mutation in patients with simple aniridia : an evaluation of mutation detection in 12 cases" 34 : 279-286, 1997
3 Brown A., "The human PAX6 mutation database" 26 : 259-264, 1998
4 Wolf MT., "Ten novel mutations found in Aniridia" 12 : 304-313, 1998
5 Thomas MG., "Structural grading of foveal hypoplasia using spectral-domain optical coherence tomography a predictor of visual acuity?" 118 : 1653-1660, 2011
6 Stoykova A., "Roles of Pax-genes in developing and adult brain as suggested by expression patterns" 14 (14): 1395-1412, 1994
7 Ton CC., "Positional cloning and characterization of a paired box-and homeobox-containing gene from the aniridia region" 67 : 1059-1074, 1991
8 St-Onge L., "Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas" 387 : 406-409, 1997
9 Gehring WJ., "Pax 6 : mastering eye morphogenesis and eye evolution" 15 : 371-377, 1999
10 Prosser J., "PAX6 mutations reviewed" 11 : 93-108, 1998
1 김종호, "선천무홍채증 환자의 PAX6 유전자의 돌연변이와 임상양상" 대한안과학회 49 (49): 1794-1800, 2008
2 Axton R., "The incidence of PAX6 mutation in patients with simple aniridia : an evaluation of mutation detection in 12 cases" 34 : 279-286, 1997
3 Brown A., "The human PAX6 mutation database" 26 : 259-264, 1998
4 Wolf MT., "Ten novel mutations found in Aniridia" 12 : 304-313, 1998
5 Thomas MG., "Structural grading of foveal hypoplasia using spectral-domain optical coherence tomography a predictor of visual acuity?" 118 : 1653-1660, 2011
6 Stoykova A., "Roles of Pax-genes in developing and adult brain as suggested by expression patterns" 14 (14): 1395-1412, 1994
7 Ton CC., "Positional cloning and characterization of a paired box-and homeobox-containing gene from the aniridia region" 67 : 1059-1074, 1991
8 St-Onge L., "Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas" 387 : 406-409, 1997
9 Gehring WJ., "Pax 6 : mastering eye morphogenesis and eye evolution" 15 : 371-377, 1999
10 Prosser J., "PAX6 mutations reviewed" 11 : 93-108, 1998
11 Hanson IM., "PAX6 mutations in aniridia" 2 : 915-920, 1993
12 Semina EV., "Mutations in the human forkhead transcription factor FOXE3 associated with anterior segment ocular dysgenesis and cataracts" 10 : 231-236, 2001
13 Grønskov K., "Mutational analysis of PAX6 : 16 novel mutations including 5 missense mutations with a mild aniridia phenotype" 7 : 274-286, 1999
14 Villarroel CE., "Molecular analysis of the PAX6 gene in Mexican patients with congenital aniridia : report of four novel mutations" 14 : 1650-1658, 2008
15 Singh S., "Missense mutation at the C-terminus of PAX6 negatively modulates homeodomain function" 10 : 911-918, 2001
16 Glaser T., "Genomic structure, evolutionary conservation and aniridia mutations in the human PAX6 gene" 2 : 232-239, 1992
17 Robinson DO., "Genetic analysis of chromosome 11p13 and the PAX6 gene in a series of 125 cases referred with aniridia" 146A : 558-569, 2008
18 Crolla JA., "Frequent chromosome aberrations revealed by molecular cytogenetic studies in patients with aniridia" 71 : 1138-1149, 2002
19 Elsas FJ., "Familial aniridia with preserved ocular function" 83 : 718-724, 1977
20 장지웅, "Congenital Aniridia: Long-term Clinical Course, Visual Outcome, and Prognostic Factors" 대한안과학회 28 (28): 479-485, 2014
21 Shaw MW., "Congenital Aniridia" 12 (12): 389-415, 1960
22 Lim HT., "Comparison between aniridia with and without PAX6 mutations : clinical and molecular analysis in 14 Korean patients with aniridia" 119 : 1258-1264, 2012
23 박신혜, "Clinical Features of Korean Patients with Congenital Aniridia" 대한안과학회 24 (24): 291-296, 2010
24 Bobilev AM., "Assessment of PAX6 alleles in 66 families with aniridia" 89 : 669-677, 2016
25 Fantes J., "Aniridia-associated cytogenetic rearrangements suggest that a position effect may cause the mutant phenotype" 4 : 415-422, 1995
26 Traboulsi EI., "Aniridia with preserved visual function : a report of four cases with no mutations in PAX6" 145 : 760-764, 2008
27 Lee H., "Aniridia : current pathology and management" 86 : 708-715, 2008
28 Semina EV., "A novel homeobox gene PITX3 is mutated in families with autosomal-dominant cataracts and ASMD" 19 : 167-170, 1998
29 Love J., "A new set of primers for mutation analysis of the human PAX6 gene" 12 : 128-134, 1998
30 D’Elia AV., "A deletion 3′ to the PAX6 gene in familial aniridia cases" 13 : 1245-1250, 2007
학술지 이력
| 연월일 | 이력구분 | 이력상세 | 등재구분 |
|---|---|---|---|
| 2023 | 평가 | 해외DB학술지평가 신청대상 (해외등재 학술지 평가) | |
| 2020-01-01 | 등재 | 등재학술지 유지 (해외등재 학술지 평가) | ![]() |
| 2017-01-01 | 등재 | 등재학술지 유지 (계속평가) | ![]() |
| 2013-01-01 | 등재 | 등재 1차 FAIL (등재유지) | ![]() |
| 2010-01-01 | 등재 | 등재학술지 유지 (등재유지) | ![]() |
| 2007-01-01 | 등재 | 등재학술지 선정 (등재후보2차) | ![]() |
| 2006-01-01 | 등재 | 등재후보 1차 PASS (등재후보1차) | ![]() |
| 2005-01-01 | 등재 | 등재후보학술지 유지 (등재후보1차) | ![]() |
| 2003-01-01 | 등재 | 등재후보학술지 선정 (신규평가) | ![]() |
학술지 인용정보
| 기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
|---|---|---|---|
| 2016 | 0.22 | 0.22 | 0.22 |
| KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
| 0.23 | 0.23 | 0.366 | 0.02 |